 drug company has ` bullied ' experts who have tried to prove that a cancer drug can be used to treat one of the most common forms of blindness .
The respected medical journal says Avastin is just as effective at tackling wet age-related macular degeneration as the current treatment , Lucentis .
Drug company Novartis has been accused of trying to block trials aimed at promoting a ` cheap , safe and effective ' treatment for sight loss would save the NHS around Â£ 102million a year